Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03494257 |
Date of registration:
|
02/04/2018 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
Scientific title:
|
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification |
Date of first enrolment:
|
September 4, 2017 |
Target sample size:
|
62 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03494257 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Greece
| | | | | | | |
Contacts
|
Name:
|
Constantine Georgakopoulos, MD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Medical School, University of Patras, Greece |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients scheduled to undergo cataract surgery by phacoemulsification.
Exclusion Criteria:
- previous ocular surgery
- ocular hypertension
- pseudoexfoliation syndrome
- pigment dispersion syndrome
- glaucoma
- history of severe cardiovascular disease, cerebral or coronary insufficiency,
depression, Raynaud's phenomenon, orthostatic hypotension or thromboangiitis
obliterans
- hypersensitivity to sulfonamides or brimonidine
Age minimum:
45 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Intraocular Pressure
|
Cataract
|
Intervention(s)
|
Drug: Brinzolamide-Brimonidine fixed combination
|
Primary Outcome(s)
|
IOP at 6 hours after surgery
[Time Frame: 6 hours postoperatively]
|
Secondary Outcome(s)
|
IOP at 12 hours after surgery
[Time Frame: 12 hours postoperatively]
|
IOP at 24 hours after surgery
[Time Frame: 12 hours postoperatively]
|
Secondary ID(s)
|
58/15.02.2018/5104
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|